River blindness: Reducing the risk in at-risk populations

Joo M. Furtado, Kevin Winthrop, Frank O. Richards

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Onchocerciasis, an eye and skin disease caused by Onchocerca volvulus, is a leading cause of infectious blindness worldwide. Most onchocercal morbidity occurs in sub-Saharan Africa, while small disease foci exist within Latin America and Yemen. Disease control and elimination campaigns currently rely primarily on mass distribution of ivermectin, a therapy that does not cure the infection, but rather prevents the development of the eye and skin disease. Within Latin America, these strategies have dramatically reduced the incidence of new infection, and blindness attributable to onchocerciasis no longer exists in the region. Within Africa, decreases in ocular disease have also been documented. New therapeutic strategies targeting the endosymbiotic bacteria Wolbachia spp. are currently being evaluated in Africa.

Original languageEnglish (US)
Pages (from-to)33-41
Number of pages9
JournalExpert Review of Ophthalmology
Volume6
Issue number1
DOIs
StatePublished - Feb 2011

Fingerprint

Ocular Onchocerciasis
Eye Diseases
Onchocerciasis
Latin America
Rivers
Blindness
Skin Diseases
Yemen
Wolbachia
Onchocerca volvulus
Disease Eradication
Ivermectin
Skin
Africa South of the Sahara
Disease control
Infection
Morbidity
Bacteria
Incidence
Therapeutics

Keywords

  • Africa
  • blindness
  • doxycycline
  • filaria
  • ivermectin
  • Latin America
  • microfilariae
  • onchocerciasis

ASJC Scopus subject areas

  • Ophthalmology
  • Biomedical Engineering
  • Optometry

Cite this

River blindness : Reducing the risk in at-risk populations. / Furtado, Joo M.; Winthrop, Kevin; Richards, Frank O.

In: Expert Review of Ophthalmology, Vol. 6, No. 1, 02.2011, p. 33-41.

Research output: Contribution to journalArticle

Furtado, Joo M. ; Winthrop, Kevin ; Richards, Frank O. / River blindness : Reducing the risk in at-risk populations. In: Expert Review of Ophthalmology. 2011 ; Vol. 6, No. 1. pp. 33-41.
@article{0566ece17799489a880af6b6cb38e4a9,
title = "River blindness: Reducing the risk in at-risk populations",
abstract = "Onchocerciasis, an eye and skin disease caused by Onchocerca volvulus, is a leading cause of infectious blindness worldwide. Most onchocercal morbidity occurs in sub-Saharan Africa, while small disease foci exist within Latin America and Yemen. Disease control and elimination campaigns currently rely primarily on mass distribution of ivermectin, a therapy that does not cure the infection, but rather prevents the development of the eye and skin disease. Within Latin America, these strategies have dramatically reduced the incidence of new infection, and blindness attributable to onchocerciasis no longer exists in the region. Within Africa, decreases in ocular disease have also been documented. New therapeutic strategies targeting the endosymbiotic bacteria Wolbachia spp. are currently being evaluated in Africa.",
keywords = "Africa, blindness, doxycycline, filaria, ivermectin, Latin America, microfilariae, onchocerciasis",
author = "Furtado, {Joo M.} and Kevin Winthrop and Richards, {Frank O.}",
year = "2011",
month = "2",
doi = "10.1586/eop.10.84",
language = "English (US)",
volume = "6",
pages = "33--41",
journal = "Expert Review of Ophthalmology",
issn = "1746-9899",
publisher = "Expert Reviews Ltd.",
number = "1",

}

TY - JOUR

T1 - River blindness

T2 - Reducing the risk in at-risk populations

AU - Furtado, Joo M.

AU - Winthrop, Kevin

AU - Richards, Frank O.

PY - 2011/2

Y1 - 2011/2

N2 - Onchocerciasis, an eye and skin disease caused by Onchocerca volvulus, is a leading cause of infectious blindness worldwide. Most onchocercal morbidity occurs in sub-Saharan Africa, while small disease foci exist within Latin America and Yemen. Disease control and elimination campaigns currently rely primarily on mass distribution of ivermectin, a therapy that does not cure the infection, but rather prevents the development of the eye and skin disease. Within Latin America, these strategies have dramatically reduced the incidence of new infection, and blindness attributable to onchocerciasis no longer exists in the region. Within Africa, decreases in ocular disease have also been documented. New therapeutic strategies targeting the endosymbiotic bacteria Wolbachia spp. are currently being evaluated in Africa.

AB - Onchocerciasis, an eye and skin disease caused by Onchocerca volvulus, is a leading cause of infectious blindness worldwide. Most onchocercal morbidity occurs in sub-Saharan Africa, while small disease foci exist within Latin America and Yemen. Disease control and elimination campaigns currently rely primarily on mass distribution of ivermectin, a therapy that does not cure the infection, but rather prevents the development of the eye and skin disease. Within Latin America, these strategies have dramatically reduced the incidence of new infection, and blindness attributable to onchocerciasis no longer exists in the region. Within Africa, decreases in ocular disease have also been documented. New therapeutic strategies targeting the endosymbiotic bacteria Wolbachia spp. are currently being evaluated in Africa.

KW - Africa

KW - blindness

KW - doxycycline

KW - filaria

KW - ivermectin

KW - Latin America

KW - microfilariae

KW - onchocerciasis

UR - http://www.scopus.com/inward/record.url?scp=79951860251&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79951860251&partnerID=8YFLogxK

U2 - 10.1586/eop.10.84

DO - 10.1586/eop.10.84

M3 - Article

AN - SCOPUS:79951860251

VL - 6

SP - 33

EP - 41

JO - Expert Review of Ophthalmology

JF - Expert Review of Ophthalmology

SN - 1746-9899

IS - 1

ER -